Duality Advisers, LP Haemonetics Corp Transaction History

Duality Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$73.85 - $86.14 $399,897 - $466,448	5,415 New	5,415 $425,000
Q1 2022 May 09, 2022	SELL	$43.77 - $63.22 $1.87 Million - $2.7 Million	-42,637 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$49.55 - $74.59 $2.11 Million - $3.18 Million	42,637 New	42,637 $2.26 Million
Q3 2021 Nov 08, 2021	SELL	$57.6 - $70.59 $3.38 Million - $4.14 Million	-58,671 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$51.81 - $118.56 $1.54 Million - $3.53 Million	29,777 Added 103.06%	58,671 $3.91 Million
Q1 2021 May 13, 2021	BUY	$111.01 - $139.48 $3.21 Million - $4.03 Million	28,894 New	28,894 $3.21 Million
Q1 2020 May 06, 2020	SELL	$74.34 - $121.82 $2.66 Million - $4.35 Million	-35,745 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$114.37 - $129.46 $4.09 Million - $4.63 Million	35,745 New	35,745 $4.11 Million

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.